Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study - Test2 - elhamkhani - TriplyDB

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

http://www.wikidata.org/entity/Q29614197

about

Mutations in the potassium channel subunit KCNE1 are associated with early-onset familial atrial fibrillation ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - Summary Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association Early-life antecedents of atrial fibrillation: place of birth and atrial fibrillation-related mortality Vitamin C for treating atrial fibrillation Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation The use of antiarrhythmics prior to cardioversion or catheter ablation for atrial fibrillation New oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease Exercise-based cardiac rehabilitation for adults with atrial fibrillation Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation Effectiveness of systematic screening for the detection of atrial fibrillation Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation The use of antiarrhythmics prior to cardioversion or catheter ablation for atrial fibrillation Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation Oral anticoagulants versus antiplatelet therapy for preventing stroke and systemic embolic events in patients with atrial fibrillation Effectiveness of systematic screening for the detection of atrial fibrillation Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks Augmented potassium current is a shared phenotype for two genetic defects associated with familial atrial fibrillation Cost of AF Ablation: Where Do We Stand?Stroke prevention in atrial fibrillation: latest clinical trials and guidelines Atrial fibrillation in a primary care practice: prevalence and management Is there a clinically significant seasonal component to hospital admissions for atrial fibrillation?Patients' perspectives on taking warfarin: qualitative study in family practice Clinical review: clinical management of atrial fibrillation - rate control versus rhythm control Risk of mortality in a cohort of patients newly diagnosed with chronic atrial fibrillation Anticoagulation for non-valvular atrial aibrillation - towards a new beginning with ximelagatran Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK.Increased risk of paroxysmal atrial fibrillation episodes associated with acute increases in ambient air pollution.Systematic screening for the detection of atrial fibrillation Vitamin C for treating atrial fibrillation Risk impact of edoxaban in the management of stroke and venous thromboembolism Biomarkers and the prediction of atrial fibrillation: state of the art Double or triple antithrombotic combination therapy in patients who need anticoagulation and antiplatelet therapy in parallel The Predictive Role of Inflammatory Biomarkers in Atrial Fibrillation as Seen through Neutrophil-Lymphocyte Ratio Mirror The Mechanism of and Preventive Therapy for Stroke in Patients with Atrial Fibrillation

P2860

Q21261490-E824893A-4396-4EBA-A6B2-EEDFA5F05F10 Q22241786-C7CAE808-5907-4DA8-BBF3-B7F4D12011A3 Q22306356-2BA288CC-A8A4-4E1E-B3B5-52F14A791FDF Q23916376-EA608A33-268F-4656-8C53-9FDA1320DBED Q24186942-E751B6D8-5A93-4106-8394-AC58611347B2 Q24187110-3089898B-2CE1-4FE8-9645-CAD6971CD9C3 Q24188262-B577A352-4E54-4D46-B267-93C3B7B013BB Q24192938-33461A7D-CDCE-4F9E-B73E-4638063A0BA6 Q24195079-07C2AE6A-2114-44DB-A2E0-BEE040D903CF Q24197643-923345EB-35A0-4574-B6F1-12026F678528 Q24197923-3C838D40-EB12-403D-A9F5-D1807BC31E76 Q24200497-2465FAA4-F8AD-4EA3-A37E-9253D8FF8903 Q24201163-8A4DD96A-234F-4045-843D-D2C024615997 Q24202280-7E0C9FCF-61EE-4C1B-8806-C088003EDC02 Q24203797-7688D7B8-E99D-4B7F-A504-C77F9CBD04BA Q24203942-0C85E097-0E5F-4E8E-B49D-2B9B4A0A66C3 Q24234397-1CFD3A0A-CA0D-4E47-B9AE-1C92286C38C2 Q24243067-5D93B487-E0FF-482F-A90E-6C3878AC5ED7 Q24244298-CDC0702C-67C6-49A2-8572-F8E23AF563F2 Q24244742-5E22D03B-E8F5-4A3D-B369-8D5AF339A3DF Q24245569-B091D013-05BD-435C-8F83-73F2785D3EE4 Q24246644-78C43A76-F775-4193-A7BD-E354BB6DBDEC Q24318897-97F634AE-C662-46EC-BC12-015E93361710 Q24605888-B08716B8-A4F0-411E-B2A6-5126A92BAB84 Q24628390-C0B7427D-86F3-469F-8554-F3D3CCF6DE09 Q24795377-1FEE1C26-5BA5-4F08-AE26-BAB61ABAF925 Q24795776-2CBAA6AC-3ED3-44BA-9FF6-D16841098B10 Q24798132-8770EDC0-3938-40B1-8E71-AD0760286CD3 Q24800344-E36E0298-8346-4F5C-ADC9-4097A04F3884 Q24804548-8873EC8C-CF66-4D2B-8EA7-BFF0657E817C Q24807132-BFEEF138-28A1-43A2-841A-61A415D46292 Q24812634-DC23A2E4-224F-4550-82CE-F70338CAA91C Q25256818-635093A4-0B29-4FB6-AF19-154AF1198F61 Q26471549-C777AFA8-9538-4E59-BA55-9049A7E14F8F Q26471829-ACF60EE2-B723-442C-BC46-7E794F3C64AC Q26738846-6FE153B7-BFCC-47AC-BBB5-5E5C2D5866EB Q26739847-374CCF78-5FBB-4589-9862-0B0085F413AF Q26741058-AA83956A-DB46-4937-ACA0-973DB3C0C111 Q26742118-7375DBFD-0692-42D9-B502-27CAAD64E0B3 Q26747263-5ED607E8-0072-483A-A406-468BA27B9444

P2860

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

http://www.wikidata.org/entity/Q29614197

description

2001 nî lūn-bûn

@nan

2001 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Prevalence of diagnosed atrial ...... ial Fibrillation (ATRIA) Study

@ast

Prevalence of diagnosed atrial ...... ial Fibrillation (ATRIA) Study

@en

type

label

Prevalence of diagnosed atrial ...... ial Fibrillation (ATRIA) Study

@ast

Prevalence of diagnosed atrial ...... ial Fibrillation (ATRIA) Study

@en

prefLabel

Prevalence of diagnosed atrial ...... ial Fibrillation (ATRIA) Study

@ast

Prevalence of diagnosed atrial ...... ial Fibrillation (ATRIA) Study

@en

P1433

Q29614197-EDC70578-EDF3-4016-9011-F6E20E6B793D

P1476

Q29614197-FA2A2ECD-4693-4684-85CD-74B06C08B01B

P2093

Q29614197-19C7EBFB-27B5-410D-815A-6853A53D5B25

Q29614197-26B8CDA0-F3F4-4E05-A417-7C3C5B80E587

Q29614197-2D45A38A-D7F4-45EF-91C1-6E77E7BBE1C6

Q29614197-402518DD-60CF-426B-ACCC-3710A87E97CE

Q29614197-6119ADF4-EE1C-4700-A19E-47FEE96DA47B

Q29614197-7EEAF19A-CF3D-45EB-ADF8-4B4F9715D18E

Q29614197-821D462F-B9AC-4BF8-A735-166688EDA790

P304

Q29614197-BF5EC2FE-A81E-425C-A150-252E4CB4843E

P31

Q29614197-E1A4FFA8-0546-4930-BCAA-2AAD153FD411

P3181

Q29614197-F0076227-2CF1-4335-8E70-F1483F4B61A0

P356

Q29614197-743577B2-3FD3-450A-8BB4-F268F9EBB3D4

P407

Q29614197-E8E8045F-AAB5-4441-989B-C829C506AA82

P433

Q29614197-5BD1F267-E10D-4F2D-93BC-148D72197737

P478

Q29614197-E8B3CFEA-6355-4722-B5C7-FF45A1E50608

P577

Q29614197-D91B0787-AEBF-43E7-AB97-E92469BC50F3

P698

Q29614197-C6C431D9-D054-4554-92D9-EAE80B07073B

P921

Q29614197-48DAAD35-3357-4F95-83D2-B870622806B1

Q29614197-F7BC7E84-A80C-4030-9239-D9FC9F37A360

P3181

P356

JAMA.285.18.2370

P1433

Journal of the American Medical Association

P1476

Prevalence of diagnosed atrial ...... ial Fibrillation (ATRIA) Study

@en

P2093

Chang Y

http://www.w3.org/2001/XMLSchema#string

Go AS

http://www.w3.org/2001/XMLSchema#string

Henault LE

http://www.w3.org/2001/XMLSchema#string

Hylek EM

http://www.w3.org/2001/XMLSchema#string

Phillips KA

http://www.w3.org/2001/XMLSchema#string

Selby JV

http://www.w3.org/2001/XMLSchema#string

Singer DE

http://www.w3.org/2001/XMLSchema#string

P304

2370-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

66298

http://www.w3.org/2001/XMLSchema#string

P356

10.1001/JAMA.285.18.2370

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

285

http://www.w3.org/2001/XMLSchema#string

P577

2001-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11343485

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

atrial fibrillation